DME

Latest News

Merck completes acquisition of EyeBio
Merck completes acquisition of EyeBio

July 15th 2024

EyeBio is developing a pipeline of clinical and preclinical candidates for the prevention and treatment of vision loss associated with retinal vascular leakage.

FDA approves faricimab-svoa 6.0 mg single-dose prefilled syringe for use in the treatment of wet AMD, DME and RVO
FDA approves faricimab-svoa 6.0 mg single-dose prefilled syringe for use in the treatment of wet AMD, DME and RVO

July 5th 2024

FDA approves Formycon’s biosimilar to Eylea, aflibercept-mrbb (Ahzantive)
FDA approves Formycon’s biosimilar to Eylea, aflibercept-mrbb (Ahzantive)

July 2nd 2024

Ophthalmologists highlight treatment options for retinal vascular diseases
Ophthalmologists highlight treatment options for retinal vascular diseases

June 27th 2024

Video Series
Video Interviews
Latest CME Events & Activities

The Ins and Outs of Lubricating Eye Drops

View More

What’s New in MGD Beyond Heating and Squeezing?

View More

Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)

View More

Community Practice Connections™: Expert Perspectives in Diabetic Macular Edema – Considering Pathogenesis & Inflammation in Treatment Selection

View More

Modern-izing Retina

September 4 - 5, 2024

View More

Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (CME Credit)

View More

Medical Crossfire®: Expert Insights in Anti-VEGF Dosing for nAMD and DME – Optimizing Reduction in Treatment Burden

View More

Community Practice Connections™: Novel Treatment Strategies in the Management of nAMD & DME - Lessons from Clinical Trial and Real-World Data

View More

Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (COPE Credit)

View More

EyeCon 2024

September 27-28, 2024

Register Now!

Join us after AAO for a CME session | In-Person + Virtual

October 19, 2024

Register Now!

(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action

View More

Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (CME/CNE Credit)

View More

Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (COPE Credit)

View More

(COPE) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action

View More

Advancing Treatment in Neovascular Retinal Disease with Novel Therapies: Insights and Strategies from Latest Real-World and Clinical Data

View More

Rapid Reviews in Retina™: Emerging Updates from Fall 2023 – Addressing the Wealth of New Data in Treatments for nAMD and DME

View More

(CME) Stratifying the Spectrum of Care in Glaucoma Management – Advancing Treatment with a Vast Armamentarium

View More

(CME) Community Practice Connections™: Advancing Management Strategies in Geographic Atrophy– Mapping Out the Continuum of Care in a New Era of Transformative Treatment

View More

(COPE) Key Advances in Cataract Surgery – Applications for New Technologies in an Ever-Changing Landscape

View More

(COPE) Community Practice Connections™: Optimizing Multidisciplinary Care for nAMD & DME – Expert Perspectives with New Dosing Strategies on the Horizon

View More

(COPE) Community Practice Connections™: Advancing Management Strategies in Geographic Atrophy– Mapping Out the Continuum of Care in a New Era of Transformative Treatment

View More

(CME) Key Advances in Cataract Surgery – Applications for New Technologies in an Ever-Changing Landscape

View More

(CME) Community Practice Connections™: Optimizing Multidisciplinary Care for nAMD & DME – Expert Perspectives with New Dosing Strategies on the Horizon

View More

Managing Ocular Toxicities in Patients With Cancer: Understanding ADCs and the ECP’s Role in Collaborative Management Therapy on the Horizon (CME Credit)

View More

Managing Ocular Toxicities in Patients With Cancer: Understanding ADCs and the ECP’s Role in Collaborative Management Therapy on the Horizon (COPE Credit)

View More

SimulatED™: Applying Advanced Treatment for nAMD & DME - Simulating New Strategies for Clinical Management

View More

Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care

View More

Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (CME Track)

View More

Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)

View More

More News

© 2024 MJH Life Sciences

All rights reserved.